Shimizu T, Osumi T, Niimi K, Nakagawa K
Arzneimittelforschung. 1985;35(7A):1117-23.
The physico-chemical properties of cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-qui nolinone, OPC-13013), a new potential antithrombotic and vasodilating drug, were studied by clarifying its elemental composition, melting point, spectra (UV, IR, NMR and mass), X-ray diffraction pattern, thermal properties, solubilities and partition coefficient. Analytical test methods such as HPLC and TLC were established for use in stability tests, and the stability study of cilostazol in an aqueous solution (acid and base) and in a solid form was carried out. Cilostazol was shown to be stable with no changes from the initial values.
西洛他唑(6-[4-(1-环己基-1H-四氮唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹啉酮,OPC-13013)是一种新型潜在抗血栓和血管舒张药物,通过明确其元素组成、熔点、光谱(紫外、红外、核磁共振和质谱)、X射线衍射图谱、热性质、溶解度和分配系数,对其物理化学性质进行了研究。建立了如高效液相色谱法和薄层色谱法等分析测试方法用于稳定性试验,并对西洛他唑在水溶液(酸和碱)及固体形式下的稳定性进行了研究。结果表明西洛他唑具有稳定性,与初始值无变化。